We read with great interest the recent article by Santagata et al. (1) on the value of intraoperative mass spectrometry during brain tumor surgery. The authors, using desorption electrospray ionization (DESI) MS, detected rapidly the tumor metabolite 2-hydroxyglutarate (2-HG) from tissue sections of surgically resected gliomas. With DESI MS the authors identified isocitrate dehydrogenase 1-mutant tumors with both high sensitivity and specificity, providing diagnostic, prognostic, and predictive information. Furthermore, 2-HG levels correlated with tumor content, thereby indicating tumor margins (1).
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In our University Hospital, using flow cytometry we have developed a rapid cellcycle protocol for intraoperative characterization of brain tumors and their margins (2). Since 2007 we have examined 56 neoplasms (21 gliomas, 25 meningiomas, 9 metastases, and 1 primary central nervous system lymphoma), and have shown that by analyzing G 0 /G 1 phase, S-phase, and mitoses fraction, high-grade tumors could be distinguished from low-grade tumors (3). Furthermore, tumors' margins could be accurately assessed in gliomas (Fig. 1) . The equipment for cellcycle analysis is widely available and of low cost. Additionally, cell-cycle analysis is operated independently of pathology evaluation and can be interpreted easily.
We have recently proposed the integration of a flow cytometer with the Cavitational Ultrasonic Surgical Aspirator (CUSA), a widely used dissecting system that allows rapid and effective tumor removal. A recent study showed that tumor cells could be analyzed by flow cytometry and isolated from the liquid CUSA fraction (4). Apart from that, we have reported that cell-cycle analysis has an additional prognostic significance. Glioma patients with G 0 /G 1 value lower than 69% and S-phase value greater than 6% were associated with worse survival (3). In conclusion, cell-cycle analysis by flow cytometry is a promising low-cost, widely available adjunct for intraoperative brain removal and should be further investigated. 
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